News Medical on MSN
Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial
Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...
Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one ...
Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...
Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...
A new malaria drug, Ganaplacide/Lumefantrine, shows over 97% cure rates in trials. This treatment is effective even where ...
A new antimalarial drug developed by Novartis is as effective as existing treatments and could help tackle rising drug ...
Critics, including some drugmakers, argue that new patent policies would make it more difficult for companies to bring ...
Scientists have created the first new anti- malaria drug in a quarter of a century to combat resistance to existing ...
The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the ...
Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ...
[NEW YORK, SciDev.Net] An international study published in the Malaria Journal claims that a widely used test for detecting malaria is delivering too many inaccurate false-negative results and is “not ...
A fungal infection solution could help eliminate up to 86% of malaria-carrying mosquitoes, offering a powerful new tool in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results